These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 1385857)
1. Antagonism of ceruletide, a cholecystokinin analog, to the neurochemical effects of the non-competitive N-methyl-D-aspartate (NMDA) receptor antagonists, phencyclidine and MK-801, on regional dopaminergic neurons in the rat brain. Kuroki T; Tatebayashi Y; Ide K; Yonezawa Y; Tsutsumi T; Matsumoto T; Hirano M; Uchimura H Neuropeptides; 1992 Mar; 21(3):167-73. PubMed ID: 1385857 [TBL] [Abstract][Full Text] [Related]
2. The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents. Bristow LJ; Hutson PH; Thorn L; Tricklebank MD Br J Pharmacol; 1993 Apr; 108(4):1156-63. PubMed ID: 8485625 [TBL] [Abstract][Full Text] [Related]
3. Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT(2C/2B) receptor antagonists: neurochemical and behavioural studies. Hutson PH; Barton CL; Jay M; Blurton P; Burkamp F; Clarkson R; Bristow LJ Neuropharmacology; 2000 Sep; 39(12):2318-28. PubMed ID: 10974315 [TBL] [Abstract][Full Text] [Related]
4. Effects of competitive and non-competitive NMDA receptor antagonists on dopamine output in the shell and core subdivisions of the nucleus accumbens. Marcus MM; Mathé JM; Nomikos GG; Svensson TH Neuropharmacology; 2001 Mar; 40(4):482-90. PubMed ID: 11249957 [TBL] [Abstract][Full Text] [Related]
5. Diazepam antagonizes effects on dopamine metabolism produced by PCP receptor agonists. Bowers MB; Morton JB Prog Neuropsychopharmacol Biol Psychiatry; 1992 Mar; 16(2):211-5. PubMed ID: 1315975 [TBL] [Abstract][Full Text] [Related]
6. The N-methyl-D-aspartate receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats. Löscher W; Annies R; Hönack D Neurosci Lett; 1991 Jul; 128(2):191-4. PubMed ID: 1834964 [TBL] [Abstract][Full Text] [Related]
7. Ceruletide inhibits phencyclidine-induced dopamine and serotonin release in rat prefrontal cortex. Etou K; Kuroki T; Kawahara T; Yonezawa Y; Tashiro N; Uchimura H Pharmacol Biochem Behav; 1998 Dec; 61(4):427-34. PubMed ID: 9802838 [TBL] [Abstract][Full Text] [Related]
8. Regional effects of MK-801 on dopamine release: effects of competitive NMDA or 5-HT2A receptor blockade. Schmidt CJ; Fadayel GM J Pharmacol Exp Ther; 1996 Jun; 277(3):1541-9. PubMed ID: 8667221 [TBL] [Abstract][Full Text] [Related]
9. Selective activation of dopaminergic pathways in the mesocortex by compounds that act at the phencyclidine (PCP) binding site: tentative evidence for PCP recognition sites not coupled to N-methyl-D-aspartate (NMDA) receptors. Rao TS; Kim HS; Lehmann J; Martin LL; Wood PL Neuropharmacology; 1990 Mar; 29(3):225-30. PubMed ID: 2158000 [TBL] [Abstract][Full Text] [Related]
10. Effects of competitive N-methyl-D-aspartate antagonists on midbrain dopamine neurons: an electrophysiological and behavioral comparison to phencyclidine. French ED; Ferkany J; Abreu M; Levenson S Neuropharmacology; 1991 Oct; 30(10):1039-46. PubMed ID: 1836840 [TBL] [Abstract][Full Text] [Related]
11. Response of extrapyramidal and limbic neurotensin systems to phencyclidine treatment. Hanson GR; Midgley LP; Bush LG; Gibb JW Eur J Pharmacol; 1995 May; 278(2):167-73. PubMed ID: 7672001 [TBL] [Abstract][Full Text] [Related]
12. Stress activation of mesocorticolimbic dopamine neurons: effects of a glycine/NMDA receptor antagonist. Morrow BA; Clark WA; Roth RH Eur J Pharmacol; 1993 Jul; 238(2-3):255-62. PubMed ID: 8405096 [TBL] [Abstract][Full Text] [Related]
13. Regional amines levels in the rat brain following intra-accumbens cholecystokinin and intraperitoneal amphetamine pre-treatment. Heidbreder C; Gewiss M; De Potter W; De Witte P Arch Int Physiol Biochim Biophys; 1992; 100(3):267-73. PubMed ID: 1382678 [TBL] [Abstract][Full Text] [Related]
15. The impact of a competitive and a non-competitive NMDA receptor antagonist on dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra. Wedzony K; Czyrak A; Maćkowiak M; Fijał K Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):517-27. PubMed ID: 8740145 [TBL] [Abstract][Full Text] [Related]
16. Phencyclidine increases forebrain monoamine metabolism in rats and monkeys: modulation by the isomers of HA966. Jentsch JD; Elsworth JD; Redmond DE; Roth RH J Neurosci; 1997 Mar; 17(5):1769-75. PubMed ID: 9030635 [TBL] [Abstract][Full Text] [Related]
17. Behavioural and neurochemical interactions of the AMPA antagonist GYKI 52466 and the non-competitive NMDA antagonist dizocilpine in rats. Bubser M; Tzschentke T; Hauber W J Neural Transm Gen Sect; 1995; 101(1-3):115-26. PubMed ID: 8695042 [TBL] [Abstract][Full Text] [Related]
18. MK-801, phencyclidine (PCP), and PCP-like drugs increase burst firing in rat A10 dopamine neurons: comparison to competitive NMDA antagonists. French ED; Mura A; Wang T Synapse; 1993 Feb; 13(2):108-16. PubMed ID: 8446919 [TBL] [Abstract][Full Text] [Related]
19. Interactions of phencyclidine receptor agonist MK-801 with dopaminergic system: regional studies in the rat. Rao TS; Kim HS; Lehmann J; Martin LL; Wood PL J Neurochem; 1990 Apr; 54(4):1157-62. PubMed ID: 2156013 [TBL] [Abstract][Full Text] [Related]
20. Non-NMDA excitatory amino acid receptors in the ventral tegmental area mediate systemic dizocilpine (MK-801) induced hyperlocomotion and dopamine release in the nucleus accumbens. Mathé JM; Nomikos GG; Schilström B; Svensson TH J Neurosci Res; 1998 Mar; 51(5):583-92. PubMed ID: 9512002 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]